Retia Medical
Series B in 2022
Retia Medical, LLC is a medical device company based in East Lansing, Michigan, focused on developing innovative monitoring solutions for high-risk patients. The company specializes in hemodynamic monitors that assess critical health metrics, particularly cardiac output, which indicates the rate of blood flow from the heart. These devices are designed to support clinicians in detecting, diagnosing, and treating life-threatening conditions during high-risk surgeries, such as cardiac, neuro, transplant, and gastrointestinal procedures. Retia Medical's technology is applicable in various healthcare settings, including intensive care units, operating rooms, and potentially emergency departments or home care. By utilizing advanced algorithms, its monitoring systems provide accurate data on blood flow, enabling healthcare providers to make informed decisions that enhance patient care for conditions like sepsis, heart failure, and multi-organ failure. The company aims to seek FDA approval for its products, which are backed by extensive validation through animal and human studies and support from industry experts.
Pear Therapeutics
Post in 2021
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.
Iridia, Inc. is a nanotechnology company based in Carlsbad, California, specializing in innovative data storage solutions utilizing DNA. Founded in 2016, Iridia has developed a pioneering DNA-based data storage system that integrates DNA polymer synthesis technology with semiconductor fabrication and electronic nano-switches. This technology allows for the writing, storing, and reading of data in a highly efficient manner, significantly reducing infrastructure requirements and environmental impact. By employing a highly-parallel format, Iridia's solution offers the potential for exceptionally high-density data storage, making it a commercially attractive option for managing large volumes of data. Formerly known as Dodo OmniData, Inc., the company rebranded to Iridia, Inc. in March 2018.
Biorez, Inc. is a medical device company focused on developing bioresorbable scaffold implants aimed at enhancing tissue regeneration in vivo. Founded in 2008 and based in New Haven, Connecticut, the company offers innovative products such as the L-C Ligament, designed for anterior cruciate ligament (ACL) reconstruction, which eliminates the need for donor tissue harvesting and serves as a superior alternative to cadaver-based materials. Biorez utilizes patented technology involving a degradable polymer, PLLA, in its orthopedic implants to promote the regeneration and augmentation of soft tissue. Among its offerings is the biorez GRAFT, a FDA-cleared device for soft tissue augmentation of the rotator cuff. The company’s bioinductive implants stabilize surgical repairs while the body rebuilds its musculoskeletal tissue, thereby facilitating quicker and safer recovery for patients and providing surgeons with effective tools to improve soft tissue repair outcomes.
Shindig
Seed Round in 2017
Shindig is a digital platform that transforms video chat for large-scale, participatory events, allowing all participants to engage in a shared online space. The platform facilitates interactive experiences where featured presenters can deliver talks, conduct interviews, and share multimedia content with a live audience of thousands. Selected audience members have the opportunity to join presenters on stage for direct interaction, creating a dynamic akin to in-person gatherings. Participants can also network and engage in private video chats, mimicking the informal conversations typical of physical events. Shindig has gained traction among notable clients and institutions, including Accenture, Amazon, and the United Nations, and has been recognized for its innovative approach to online engagement, receiving the 2017 Cool Vendor Award in Social Collaboration from Gartner. Founded by Steve Gottlieb, a serial entrepreneur and former CEO of TVT Records, Shindig has secured significant investment to support its growth in the virtual event space.
Gelesis
Private Equity Round in 2015
Gelesis, Inc. is a biotechnology company based in Boston, Massachusetts, focused on developing innovative therapies for gastrointestinal-related chronic diseases, particularly obesity and its associated conditions. Founded in 2006, Gelesis utilizes a mechanobiology technology platform to create first-in-class therapeutics. Its flagship product, PLENITY, is an FDA-cleared, orally administered aid for weight management, comprised of hydrogel particles that expand in the stomach to promote a feeling of fullness and help reduce caloric intake. The company's pipeline also includes potential treatments for non-alcoholic fatty liver disease, type 2 diabetes, and chronic idiopathic constipation, addressing a range of metabolic and digestive health issues.
ZOZI designs and develops a web-based bookings, payments, and customer management software for tour, activity, and event businesses. It offers introductory flight lessons, vineyard tours and wine tasting by horseback, diving for abalone, ice climbing frozen waterfalls, celebrity and athlete experiences, and various accessible adventures. The company also provides weekend getaways and vacation packages for customers. ZOZI was founded in 2007 and is based in San Francisco, California.
Gelesis, Inc. is a biotechnology company based in Boston, Massachusetts, focused on developing innovative therapies for gastrointestinal-related chronic diseases, particularly obesity and its associated conditions. Founded in 2006, Gelesis utilizes a mechanobiology technology platform to create first-in-class therapeutics. Its flagship product, PLENITY, is an FDA-cleared, orally administered aid for weight management, comprised of hydrogel particles that expand in the stomach to promote a feeling of fullness and help reduce caloric intake. The company's pipeline also includes potential treatments for non-alcoholic fatty liver disease, type 2 diabetes, and chronic idiopathic constipation, addressing a range of metabolic and digestive health issues.
Ubiquity Global Services
Series B in 2013
Ubiquity Global Services, Inc. is a multinational outsourcing organization specializing in customer support and business process services. Founded in 2012 and headquartered in New York City, the company operates globally with additional locations in Omaha, Nebraska; Manila and Bacolod in the Philippines; San Salvador, El Salvador; Bogota, Colombia; Amsterdam, the Netherlands; Budapest, Hungary; Wilkes-Barre, Pennsylvania; and Lisbon, Portugal. Ubiquity offers a wide range of services, including call center operations, sales and retention support, social media management, and risk and compliance services such as fraud investigation and chargeback management. The company is recognized for its expertise in the fintech and emerging payments sectors, providing live customer management and interactive voice response solutions. Ubiquity employs advanced technology to enhance operational efficiency and deliver actionable business intelligence, while also developing artificial intelligence and machine learning technologies at its innovation hub in Amsterdam to optimize customer service performance.
Shindig
Seed Round in 2012
Shindig is a digital platform that transforms video chat for large-scale, participatory events, allowing all participants to engage in a shared online space. The platform facilitates interactive experiences where featured presenters can deliver talks, conduct interviews, and share multimedia content with a live audience of thousands. Selected audience members have the opportunity to join presenters on stage for direct interaction, creating a dynamic akin to in-person gatherings. Participants can also network and engage in private video chats, mimicking the informal conversations typical of physical events. Shindig has gained traction among notable clients and institutions, including Accenture, Amazon, and the United Nations, and has been recognized for its innovative approach to online engagement, receiving the 2017 Cool Vendor Award in Social Collaboration from Gartner. Founded by Steve Gottlieb, a serial entrepreneur and former CEO of TVT Records, Shindig has secured significant investment to support its growth in the virtual event space.
ZOZI designs and develops a web-based bookings, payments, and customer management software for tour, activity, and event businesses. It offers introductory flight lessons, vineyard tours and wine tasting by horseback, diving for abalone, ice climbing frozen waterfalls, celebrity and athlete experiences, and various accessible adventures. The company also provides weekend getaways and vacation packages for customers. ZOZI was founded in 2007 and is based in San Francisco, California.
Shindig
Pre Seed Round in 2010
Shindig is a digital platform that transforms video chat for large-scale, participatory events, allowing all participants to engage in a shared online space. The platform facilitates interactive experiences where featured presenters can deliver talks, conduct interviews, and share multimedia content with a live audience of thousands. Selected audience members have the opportunity to join presenters on stage for direct interaction, creating a dynamic akin to in-person gatherings. Participants can also network and engage in private video chats, mimicking the informal conversations typical of physical events. Shindig has gained traction among notable clients and institutions, including Accenture, Amazon, and the United Nations, and has been recognized for its innovative approach to online engagement, receiving the 2017 Cool Vendor Award in Social Collaboration from Gartner. Founded by Steve Gottlieb, a serial entrepreneur and former CEO of TVT Records, Shindig has secured significant investment to support its growth in the virtual event space.
Reliant Pharmaceuticals
Series D in 2003
Reliant Pharmaceuticals is a company focused on developing and marketing cardiovascular pharmaceutical products. Established in 1999 and headquartered in Liberty Corner, New Jersey, it offers a range of medications designed to treat conditions such as hypertension, elevated cholesterol, and acid reflux disease. Its product portfolio includes Axid for acid reflux, InnoPran XL and DynaCirc CR for hypertension, Omacor for high triglycerides, and Rythmol SR. The company is involved in acquiring and developing branded pharmaceuticals, as well as potential products that are in mid- to late-stage clinical development. Reliant Pharmaceuticals distributes its products primarily to physicians in primary care, cardiovascular, and specialized medical fields.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.